Pharmaceutical

EditCo Bio secures access to Promega’s technologies in licensing deal

EditCo Bio has entered a licensing agreement to secure access to Promega’s protein-tagging and bioluminescent identification technologies.

Apr 24, 2025 - 06:00
EditCo Bio secures access to Promega’s technologies in licensing deal
EditCo Bio has entered a licensing agreement to secure access to Promega’s protein-tagging and bioluminescent identification technologies.
Read the original article

Tags:

Previous Article

Synthetic hormones and the future of contraception

Next Article

FDA layoffs and priority review programme’s lapse disrupt rare disease pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Patients loved Carbon Health’s diabetes program. That couldn’t save it

STAT+: Patients loved Carbon Health’s diabetes program....

Nov 13, 2023

STAT+: FDA scolds Novartis over a misleading TV ad for a breast cancer treatment

STAT+: FDA scolds Novartis over a misleading TV ad for ...

Jan 20, 2024

STAT+: Eye docs urge Medicare to lower insurance hurdles amid shortage of repackaged Avastin

STAT+: Eye docs urge Medicare to lower insurance hurdle...

Oct 14, 2023